{
    "nctId": "NCT01555944",
    "briefTitle": "Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines",
    "officialTitle": "Screening and Management of Cardiovascular Risk in Belgian Women Aged > or = 65 Years With Metastatic Breast Cancer Before and After Anthracycline Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "cardiovascular risk factors",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women aged 65 years old or more\n* with confirmed metastatic breast cancer (MBC)\n* who will be treated with anthracyclines in first or second line\n* who have a Karnofsky score at baseline of 50\n* who agree and are able to fill in the EORTC QLQ-C30 questionnaire\n* who gave their informed consent\n\nExclusion Criteria:\n\n* women having contra-Indications for anthracyclines\n* women aged \\< 65 years old\n* with no metastatic breast cancer\n* who will not be eligible for an anthracycline treatment in first or second line MBC\n* who have a Karnofsky less than 50\n* who disagree or are unable to fill in the EORTC QLQ-C30 questionnaire\n* women refusing or not having signed their informed consent",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}